Home / Valproic Acid / United States
US ATC N03AG01 · updated 2 Nov 2026
Valproic Acid shortage in United States
Is there a Valproic Acid shortage in United States?
Yes. As of 2 Nov 2026, 2 Valproic Acid products are reported short in United States, the first since 30 Dec 2020. No return date has been given. Main reason: increased demand.
Also short in Canada, France, Italy, Spain, Austria, Czechia, Sweden, Japan, New Zealand. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Valproate Sodium, Injection, 100 mg/1 mL (NDC 63323-494-05) | Fresenius Kabi USA, LLC | 30 Dec 2020 | not given | Increased demand Demand increase for the drug |
| US | Valproate Sodium, Injection, 500 mg/5 mL (NDC 0143-9785-10) | Hikma Pharmaceuticals USA, Inc. | 30 Dec 2020 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).